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Medications as a Risk
Factor in Falls by Older
Adults with and without
Intellectual Disabilities
by  Patricia W. Slattum,
Pharm.D., Ph.D. and 
Edward F. Ansello, Ph.D.
Educational Objectives
1. Review common intrinsic and
extrinsic risk factors for falls by
older adults.
2. Compare risk factors for older
adults with and without intellectual
disabilities.
3. Focus on medications as a risk
factor among a complexity of risk
factors.
4. Suggest steps to improve appro-
priateness of medication regimens,
as a step to help reduce risk for
falls.
Background
Falls are a too common and much
feared aspect of life for many older
adults. The consensus from
research is that about 30-40% of
community-dwelling adults ages
65+ have fallen in the past year,
increasing to about half of those
age 80 and above. A new study
(Hsieh et al, 2012) using retrospec-
tive data of 1,515 adults with intel-
lectual disabilities found a similar
percentage among those 65+, with
no further sub-analysis among
those 80 and above. Importantly,
Hsieh and colleagues found rates of
falls among younger ages that were
comparable to rates of older adults
without intellectual disabilities. Our
Virginia Geriatric Education Center
team found well over a dozen defi-
nitions of what constitutes a fall,
and this muddles generalizations
from studies employing a variety of
criteria. Our team chose as most
useful: "A fall is an unplanned
descent to the floor (or an extension
of the floor) with or without injury."
So, feeling dizzy and choosing to
sit would not be considered a fall
but other unintentional losses of
balance that "plopped" one onto a
chair or bed rather than onto the
floor would be. 
Research suggests that interven-
tions to reduce risk for falls tend to
be most successful when the inter-
vention is multi-faceted and targets
those with the most critical risk fac-
tors.  This case study will review
various risk factors briefly but can-
not be comprehensive. It will con-
centrate its focus more on medica-
tions, which, in fact, are associated
with several of the most critical risk
factors. Even there, the appraisal is
limited by space. 
Falls as a Signal
"Causes" of falls are often indefi-
nite and complex, so health care
researchers and practitioners have
identified a number of risk factors
that are associated with falling.
These risk factors are clinically
identified as either intrinsic or
extrinsic. Intrinsic factors refer to
characteristics or conditions of the
individual, such as vision, gait, and
health history. Extrinsic factors
refer to conditions outside the indi-
vidual, such as environmental haz-
ards but also medications taken by
the individual, brought into the
body, that others may have pre-
scribed. 
As might be seen, falls may be a
signal of other geriatric syndromes,
such as falling when rushing to the
bathroom because of incontinence
or falling because of worsening
sensory input from poor vision or
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2hearing. Falls may be the cause or
the effect of frailty. Falls may pre-
cipitate a downward cascade in
quality of life. And so on. Clearly,
reducing one's risk of falls deserves
great attention from older adults,
family caregivers, health care
providers, agency staff, and others
who are concerned.
Fall Risk Factors
Intrinsic and extrinsic risk factors
tend not to exist separately, in isola-
tion, for they are frequently inter-
related, as when balance disorders
lead to medications being pre-
scribed and vice versa. There is an
interaction and probable synergism
among multiple risk factors. They
can relate and multiply. The risk of
falling increases as the number of
risk factors increases. There is not a
direct and linear cause and effect.
But identifying and addressing risk
factors for falling does help to
reduce its likelihood.
Intrinsic Risk Factors
Some of the common intrinsic risks
include: lower extremity weakness;
previous falls; gait and balance dis-
orders; impaired vision; depression;
functional and cognitive impair-
ment; dizziness; low body weight;
urinary incontinence; orthostatic/
postural hypotension (a notable
drop in blood pressure from sitting
to rising); female gender; and being
over age 80. Some intrinsic risk
factors are simply not modifiable;
some are.
Extrinsic Risk Factors
The more important extrinsic risk
factors include: medications, espe-
cially polypharmacy (taking four or
more prescription medications);
psychotropic medications (medica-
tions that affect the mind and
behavior); and environmental haz-
ards, such as poor lighting; loose
rugs or carpets; lack of bathroom
safety equipment, and improper
foot wear, like slippers that provide
no support. Generally, extrinsic fac-
tors are modifiable.
The Most Critical Risk Factors
For more than 20 years, geriatrician
Mary Tinetti and colleagues have
focused on risks for falling and
interventions to reduce those risks.
Her landmark randomized con-
trolled intervention trials with com-
munity-dwelling elders in Con-
necticut (Tinetti et al., 1994) and
subsequent work (e.g., Tinetti &
Kumar, 2010) have identified the
most critical risk factors for inter-
vention. Pragmatically, she argues
that health care practitioners should
target the risks that they can fix
most readily, through screening and
interventions (Tinetti & Kumar,
2010). Tinetti and Kumar's updated
fall risk factors suggest that screen-
ing and intervention should target
older adults with: previous falls;
balance impairment; muscle weak-
ness; dizziness/orthostasis; female
sex; low body weight; diabetes; gait
impairment; vision impairment;
and/or cognitive impairment. 
Notably, several of these factors
may precipitate or be the result of
medications. Hsieh et al. (2012)
identified similar significant risk
factors among adults with intellec-
tual disabilities: female sex, having
arthritis, having a seizure disorder,
polypharmacy, using walking aids,
and having difficulty lifting or car-
rying over 10 pounds. Specifically,
among those without a seizure dis-
order, Hsieh and colleagues found
statistically significant  risk factors
for falls were having a higher level
of intellectual disability, having
arthritis, back pain, a heart condi-
tion, urinary incontinence, using a
walking aid, and having difficulty
walking three blocks.  
Medications as a Risk Factor
Older adults may be at greater risk
of falling because they may have
multiple chronic conditions like
high blood pressure, arthritis, sleep
problems, etc., for which medica-
tions are prescribed; moreover,
there are likely multiple prescribers
involved who may or may not
know what others are prescribing
for the older adult. The older adult
may be taking multiple medica-
tions, both prescribed and over-the-
counter, and there may be a signifi-
cant mix of medications being
taken. This mix may lead to unin-
tended consequences, including
lessened or heightened therapeutic
results or adverse drug events. Note
that these situations apply across
the board to older adults with or
without lifelong disabilities. Many
medications go to market having
few adults ages 75 and above in the
clinical trials that tested the drug. 
Surprisingly, there have been few
randomized controlled trials to
study the effect of a specific med-
ication on risk of falling. And, as
noted earlier, interpretation of the
studies has been complicated by
variations in fall definitions. How-
ever, psychotropic medications are
strongly related to risk for falls; the
use of sedatives and hypnotics,
antidepressants, and benzodi-
azepines (prescribed for anxiety,
insomnia, muscle spasms) demon-
3strates a significant association with
falls in older adults (Wolcott et al.,
2009; AGS/BGS, 2010, 2011).
Importantly, several of the most fre-
quent manifestations of adverse
drug events are risk factors them-
selves for falling; these adverse
drug effects include orthostatic/pos-
tural hypotension (a precipitous
drop in blood pressure when ris-
ing), bradycardia (heart rate that is
too slow), cognitive changes, and
dizziness. Falling may represent the
final common pathway of cumula-
tive adverse drug events (Agostini
& Tinetti, 2002). So, it is prudent to
take steps to ensure that medica-
tions are both appropriate and taken
correctly. 
Case Study #1
Anthony, age 43, has mild to mod-
erate intellectual disability due to
difficulties at birth during delivery.
He is the youngest of four children
and is doted upon by his three sis-
ters. He lives with his parents and
participates in a sheltered workshop
where he helps assemble materials
for promotions and marketing con-
tracts that the agency obtains. He's
active in his church and accompa-
nies his father to monthly meetings
and outings of his Knights of
Columbus chapter. Only slightly
overweight, he nonetheless has high
blood pressure, which his physician
is treating aggressively. Recently,
he began experiencing dizziness
and mood changes and he has com-
municated his apprehension about
leaving the safety of his home. He
sits in his room. For his high blood
pressure, Anthony takes hydro-
chlorothiazide 25 mg/metoprolol
succinate 200 mg (Dutoprol®)
daily.  He was recently prescribed
lorazepam 0.5 mg (Ativan®) daily
for symptoms of anxiety.   His dose
of Dutoprol® was recently
increased to the maximum recom-
mended dose.  Metoprolol causes
dizziness in 3-10% of adults and
bradycardia in 5% of patients.  The
higher the dose, the greater the risk
of experiencing these adverse drug
events.  It is important to ask about
symptoms of dizziness and to moni-
tor Anthony’s pulse and blood pres-
sure (sitting and standing) to be
sure that he is not experiencing side
effects that may increase his risk of
falling.  His symptoms of dizziness
may be related to his blood pressure
medication, considering that the
dose of his blood pressure medica-
tions was increased just before the
dizziness started.  Fortunately, there
are many different medications
available to manage high blood
pressure and an alternative may not
result in the same side effects.
Lorazepam also increases Antho-
ny’s risk of falling.  This medica-
tion should be used temporarily at
the lowest possible dose.  Long
term treatment with benzodi-
azepines should be avoided when-
ever possible.  Non-medication
therapy can be helpful in both
hypertension (exercise and a
healthy diet) and anxiety (cognitive
behavioral therapy or relaxation
techniques).
Case Study #2
Ethel is a 72-year-old widow who
lives alone in the home where she
and her husband raised their two
children. They each live nearby.
While she has always considered
herself to be healthy, she has
recently been plagued by painful
arthritis, troubling problems with
her vision, joint pain, and cardio-
vascular problems. Her appoint-
ment book is filled with names of
physicians. Last weekend, she fell
and bruised herself badly when
leaving her house. Ethel is taking
one acetaminophen 500 mg
(Tylenol Extra Strength®) three
times per day for arthritis.  For pain
unrelieved by acetaminophen, she
takes tramadol 100 mg (Ultram®)
three times per day as needed.
Recently she has been taking tra-
madol two-three times a day.  Ethel
also takes zolpidem 10 mg (Ambi-
en®) occasionally when her arthri-
tis pain makes it difficult for her to
fall asleep.  For her cardiovascular
problems, Ethel takes atorvastatin
20 mg (Lipitor®) daily to lower her
LDL cholesterol and hydro-
chlorothiazide 25 mg daily for high
blood pressure. Ethel’s most signifi-
cant medication-related risk for
falling is her use of psychotropic
medications, particularly as needed
tramadol and zolpidem.  To reduce
her use of tramadol, Ethel can try
increasing her scheduled aceta-
minophen dose to 1000 mg two-
three times per day.  Topical anal-
gesics may also help.  Management
of chronic pain is important for
quality of life, so it is necessary to
balance the risks and benefits of
drug treatments.  Zolpidem should
only be used for the short-term
treatment of insomnia and at the
lowest effective dose.  Older adults
and women are at higher risk for
adverse events (impaired balance
and cognition, falls) from zolpidem,
and a lower dose of 5 mg daily as
needed is recommended. Taking
tramadol and zolpidem simultane-
ously is particularly troublesome, as
the adverse events are exaggerated.
Blood pressure lowering medica-
tions can also increase the risk of
falling, so periodic monitoring to be
sure that the blood pressure does
not drop too low when standing is
also important. Tramadol can also
enhance the orthostatic hypotensive
effects of hydrochlorothiazide.
Whenever multiple medications are
being taken, their interactions with
each other should be considered.
Interventions Related to 
Medications
Tinetti and colleagues (1994, 2010)
identified several interventions that
reduced falls by older adults.
(Notably, even the most compre-
hensive interventions do not elimi-
nate the risk for falls.) When ortho-
static/postural hypotension was pre-
sent, with the individual experienc-
ing a precipitous drop in blood
pressure on rising, behavior modifi-
cation and medication review/
change proved helpful. For exam-
ple, teaching the individual to rise
from a chair more slowly and to use
a chair with a higher and more firm
seat lessened the risk, as did, of
course, modifying medications that
can cause the drop in blood pres-
sure in the first place. Use of ben-
zodiazepines (psychotropics for
anxiety, insomnia, muscle spasms,
etc) may be modifiable, with taper-
ing off sometimes possible; if not,
instruction in appropriate use
helped. Multiple medications in
one's drug regimen which prompted
involvement of the person's primary
care provider to conduct serious
review of each medication's indica-
tion, dosage, adverse effects, inter-
actions, and so on, resulted in
changes in medications and
improved communication among
providers. While Hsieh et al. (2012)
employed secondary analysis of
data from the Longitudinal Health
and Intellectual Disability Study
and did not involve clinical inter-
ventions, it seems reasonable, given
the similarities among risk factors
for falls by older adults with and
without intellectual disabilities, that
a focus on medications is prudent.
Notably, seizure disorders and other
health conditions (arthritis, heart
condition, back pain, and urinary
incontinence) for which prescribed
medications are the most common
treatment modality emerged as the
most important risk factors, as well
as the risk factors for fall-related
injuries requiring medical care
(Hsieh et al., 2012). 
Some more specific suggestions
follow.
The Medication History
Older adults, family caregivers, and
health care providers can help
reduce the risk for falls by careful
appraisal of the medications that the
older adult is taking. An accurate
medication history is important but
can take some detective work to
obtain. The medication history
needs to be comprehensive. The
current medication list should
include: prescription medications,
over the counter medications,
dietary supplements or herbal prod-
ucts, alcohol and other recreational
drugs (AGS/BGS, 2010, 2011). For
each medication, it is necessary to
record the dose, time(s) taken each
day, frequency of use for “as need-
ed” medications, and indication
(why the person is taking the med-
ication). In the latter case, there are
occurrences where someone is still
taking a drug long after it ceased
being needed. Discrepancies
between the patients’ understanding
of what they should be taking, what
they actually are taking, and what
healthcare providers record on their
medication lists are common.
Screening for Medication-Related
Fall Risk
The “Brown Bag” review where all
medications are literally or figura-
tively put together in a paper bag
offers an opportunity to determine
how the older adult patient is actu-
ally taking medications and to
inquire about medication effective-
ness and possible adverse events
(Steinman & Hanlon, 2010). Signif-
icant questions to ask include: 
1) Is the person taking more than
four medications? 
2) Is he or she taking psychotropic
medications? These include seda-
tives, antipsychotics, antidepres-
sants, antiepileptic medications,
benzodiazepines, and anticholiner-
gic medications (which block
receptor sites of the neurotransmit-
ter acetylcholine). Many of these
medications appear on the Beers list
of potentially inappropriate medica-
tions older adults
(www.americangeriatrics.org/
health_care_professionals/
clinical_practice/clinical_
guidelines_recommendations/
2012).  Psychotropic medications
are among the most frequently pre-
scribed for individuals with devel-
opmental disabilities, because of
anxieties, spasms, etc. Also, as per-
sons with Down’s syndrome age,
they are more likely to be taking
antiepileptic medications (Sipes et
al., 2011).
3) Is the person taking medications
that cause bradycardia (slowing of
heart beat)? Such drugs include
digoxin, β blockers (metoprolol,
atenolol®), non-dihydropyridine
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calcium channel blockers (dilti-
azem, verapamil), and amiodarone.
Note that here and in the following
we name just some of the drugs
within each type.
4) Is the person taking medications
that can cause orthostatic/postural
hypotension? These drugs include
the very large number of antihyper-
tensives, anti-emetic phenothiazines
(promethazine, prochlorperazine),
tricyclic antidepressants (amitripty-
line, nortriptyline), anti-Parkinson-
ian drugs, diuretics, and any phos-
phodiesterase-5 enzyme inhibitor
(Viagra®, Cialis®). Cardiovascular
disease, including hypertension, is
the most common cause of mortali-
ty in individuals with developmen-
tal disabilities.
5) Is the person experiencing symp-
toms that might be an adverse drug
event? Such symptoms include
blurred vision, dizziness or light-
headedness, sedation or decreased
alertness, confusion or impaired
judgment, compromised neuromus-
cular function, and anxiety.
Issues Significant for Those with
Developmental Disabilities
Psychotropic medication use with-
out a documented indication is
common. Medication adherence,
particularly in community settings,
may be a challenge. Side effects
can worsen spasticity, worsen
extremity weakness or other symp-
toms related to the underlying dis-
ability. The risk versus benefit of
each medication must be consid-
ered, and the balance may shift as
the individual ages. "As needed"
medications may be especially
problematic, as monitoring by fami-
ly and agencies may be inconsistent
at best (Kim et al, 2011).  
Vitamin D to Reduce Fall Risk
There is a protective effect of vita-
min D supplementation on fall pre-
vention in community-dwelling
older adults and among adults with
intellectual disabilities  The effect
of vitamin D on fall reduction is
significant, when taken for longer
than six months, in a dosage of  800
IU or greater, and in the form of
cholecalciferol therapy (Vitamin
D3) (Bischoff-Ferrari et al., 2004;
Kalyani et al., 2010).  Vitamin D
decreases the risk of falling by
improving lower extremity muscle
strength and balance.  It also
improves calcium absorption and
bone health, reducing the risk of
fracture if a fall occurs.
Adults with developmental disabili-
ties may be at increased risk of
osteoporosis due to antiepileptic
medications, lack of weight bearing
exercise, use of steroids such as
prednisone, and long term use of
proton pump inhibitors for acid
reflux and chronic indigestion. Any
of these factors may increase the
risk for osteoporosis, with the risk
increasing as the number of these
risk factors rises.  Having osteo-
porosis increases the risk of a frac-
ture when a fall occurs, so main-
taining bone health is critical.
Summary 
Tinetti and colleagues (1994, 2010)
and others have suggested strate-
gies to reduce risks for falling that
are applicable to adults with or
without lifelong disabilities. Med-
ication review and careful scrutiny
of effects, and more engagement
with the primary care provider are
among these. For adults with life-
long disabilities, family caregivers
and agency staff may need to
become more vigilant in monitoring
medications, informing multiple
prescribers, overseeing improve-
ments in diet and exercise, and
other steps to inform and engage
these adults in their own health
care. Group homes may wish to
designate a medication manager.
Older adults, family caregivers,
and/or agency staff should keep a
medication list (see 
www.medsandaging.org/
documents/PersonalMedList_000.
pdf) and consult with a physician,
nurse practitioner, or pharmacist
before using over-the-counter med-
ication or herbal supplements. 
Study Questions
1. Among the many intrinsic and
extrinsic risk factors for falls, why
are medications a prudent place to
focus?
2. The relatively scarce research on
falls by older adults with lifelong
disabilities identifies seizure disor-
ders as a special risk. Why is this
and what are some practical impli-
cations?
3. Identify three or more things to
look for in conducting a Brown Bag
review of medications as a risk fac-
tor for falls?  
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